IL Science Co., Ltd. (KOSDAQ: 307180)
South Korea
· Delayed Price · Currency is KRW 2,640.00
-30.00 (-1.12%)
Dec 19, 2024, 9:00 AM KST
IL Science Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Revenue | 74,194 | 39,078 | 49,165 | 48,635 | 17,553 | 20,281 |
| Revenue Growth (YoY) | 63.71% | -20.52% | 1.09% | 177.08% | -13.46% | - |
| Cost of Revenue | 57,615 | 34,084 | 39,093 | 35,143 | 15,163 | 15,147 |
| Gross Profit | 16,579 | 4,994 | 10,072 | 13,492 | 2,390 | 5,134 |
| Selling, General & Admin | 11,343 | 9,868 | 8,195 | 9,583 | 6,543 | 3,435 |
| Research & Development | 1,345 | 1,313 | 1,071 | 640.34 | 586.94 | 232.83 |
| Other Operating Expenses | 333.55 | 264.77 | 173.23 | 143.62 | 140.22 | 64.19 |
| Operating Expenses | 23,717 | 22,107 | 10,793 | 10,962 | 7,503 | 4,217 |
| Operating Income | -7,138 | -17,113 | -721.07 | 2,529 | -5,113 | 917.58 |
| Interest Expense | -7,840 | -3,784 | -2,975 | -1,583 | -463.24 | -298.42 |
| Interest & Investment Income | 1,002 | 541.82 | 127.03 | 63.04 | 45.67 | 63.99 |
| Earnings From Equity Investments | 83.42 | -60.96 | - | - | - | - |
| Currency Exchange Gain (Loss) | 217.05 | -86.98 | -312.36 | -352.4 | -0.54 | -0.13 |
| Other Non Operating Income (Expenses) | 7,127 | 1,780 | 5,686 | -8,019 | 489.76 | -3,323 |
| EBT Excluding Unusual Items | -6,549 | -18,723 | 1,805 | -7,362 | -5,042 | -2,640 |
| Gain (Loss) on Sale of Investments | 628.97 | 31.78 | 93.23 | 2.32 | 106.97 | -77.26 |
| Gain (Loss) on Sale of Assets | 43.48 | 36.71 | 59.37 | 516.17 | - | 11.03 |
| Asset Writedown | - | - | -595.08 | -591.07 | - | - |
| Pretax Income | -5,939 | -18,619 | 1,366 | -7,422 | -4,935 | -2,707 |
| Income Tax Expense | 589.87 | -538.06 | -720.31 | 253.94 | -76.19 | 19.74 |
| Earnings From Continuing Operations | -6,529 | -18,081 | 2,087 | -7,676 | -4,858 | -2,726 |
| Minority Interest in Earnings | -1,165 | -475.77 | -148.49 | -853.53 | 292.81 | - |
| Net Income | -7,694 | -18,557 | 1,938 | -8,529 | -4,566 | -2,726 |
| Net Income to Common | -7,694 | -18,557 | 1,938 | -8,529 | -4,566 | -2,726 |
| Shares Outstanding (Basic) | 26 | 25 | 23 | 21 | 21 | 15 |
| Shares Outstanding (Diluted) | 26 | 25 | 27 | 21 | 21 | 15 |
| Shares Change (YoY) | 8.37% | -7.76% | 26.89% | 4.14% | 33.45% | - |
| EPS (Basic) | -290.52 | -742.10 | 84.26 | -399.22 | -222.56 | -177.36 |
| EPS (Diluted) | -316.16 | -742.10 | -79.74 | -399.22 | -223.00 | -177.36 |
| Free Cash Flow | -11,628 | -10,246 | -4,723 | -14,806 | -11,718 | -6,078 |
| Free Cash Flow Per Share | -439.04 | -409.73 | -174.21 | -693.02 | -571.21 | -395.38 |
| Gross Margin | 22.35% | 12.78% | 20.49% | 27.74% | 13.62% | 25.32% |
| Operating Margin | -9.62% | -43.79% | -1.47% | 5.20% | -29.13% | 4.52% |
| Profit Margin | -10.37% | -47.49% | 3.94% | -17.54% | -26.01% | -13.44% |
| Free Cash Flow Margin | -15.67% | -26.22% | -9.61% | -30.44% | -66.76% | -29.97% |
| EBITDA | -2,771 | -14,017 | 1,276 | 3,423 | -4,582 | 1,252 |
| EBITDA Margin | -3.73% | -35.87% | 2.59% | 7.04% | -26.10% | 6.17% |
| D&A For EBITDA | 4,367 | 3,097 | 1,997 | 893.35 | 531.32 | 333.94 |
| EBIT | -7,138 | -17,113 | -721.07 | 2,529 | -5,113 | 917.58 |
| EBIT Margin | -9.62% | -43.79% | -1.47% | 5.20% | -29.13% | 4.52% |
| Advertising Expenses | - | 687.88 | 367.54 | 3,438 | 1,127 | 19.33 |
Source: S&P Capital IQ. Standard template. Financial Sources.